Furmonertinib Combined With Local Therapy in Inoperable or Surgery-Refusing Early-Stage Non-Small Cell Lung Cancer:A Single-arm, Phase II Study
NCT07517640 · NOT YET RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Shanghai Pulmonary Hospital Shanghai China. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Shanghai Pulmonary Hospital Shanghai China.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Shanghai Pulmonary Hospital Shanghai China currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Shanghai Pulmonary Hospital Shanghai China conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.